5 Best Fortune 500 Dividend Stocks to Buy Now

2. Gilead Sciences, Inc. (NASDAQ:GILD)

Number of Hedge Fund Holders: 58 

Dividend Yield as of October 18: 4.40%

Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines. It is one of the major large cap stocks to invest in. On October 11, the US Food and Drug Administration granted priority review to Gilead Sciences’ application approval of Trodelvy to treat patients with a type of breast cancer. 

Among the hedge funds being tracked by Insider Monkey, Boston-based investment firm Arrow Street Capital is a leading shareholder in Gilead Sciences, Inc. (NASDAQ:GILD), with 15.7 million shares worth more than $968 million. 

In its Q4 2021 investor letter, ClearBridge Investments, an asset management firm, highlighted a few stocks and Gilead Sciences, Inc. (NASDAQ:GILD) was one of them. Here is what the fund said:

“Other pharma companies are providing solutions as well. Biopharmaceutical company Gilead Sciences’ remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication administered by intravenous infusion; it can shorten the time to recovery in hospitalized patients and reduce the risk of hospitalization and death in non-hospitalized patients.”